Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 02215, USA.
Clin Liver Dis. 2010 Aug;14(3):531-46. doi: 10.1016/j.cld.2010.05.003. Epub 2010 Jun 14.
There have been major advances in the field of hepatitis B (HBV) over the last few decades. These advances have resulted in the understanding of the natural history of chronic HBV infection, effective vaccines against the virus, sensitive assays for screening and monitoring of treatment, and effective treatments for viral suppression, all leading to improved outcomes. Debates and controversies remain, however, over the ideal management strategies of patients with chronic hepatitis B. To eradicate HBV, the global community needs to improve current preventive, screening, and treatment strategies.
在过去的几十年中,乙型肝炎(HBV)领域取得了重大进展。这些进展使人们对慢性 HBV 感染的自然史、针对该病毒的有效疫苗、用于筛查和监测治疗的敏感检测方法以及有效的病毒抑制治疗有了更深入的了解,从而改善了治疗效果。然而,对于慢性乙型肝炎患者的理想管理策略,仍然存在争议。为了消灭 HBV,全球社会需要改进现有的预防、筛查和治疗策略。